NOV 28, 2015 6:11 AM PST

A Combination of Drugs and Immunotherapy To Treat Breast Cancer

WRITTEN BY: Kara Marker
The American Cancer Society predicts that over 40,000 women will die from breast cancer this year, and that's just in the United States. As motivated as ever, scientists from the University of Basel have developed a novel treatment plan to target breast cancer. 

With their results published in Science Translational Medicine, the team from Switzerland successfully created an "antibody-drug conjugate" (ADC) to pair with immunotherapy to attack cancerous cells. The ADC stimulates the immune system to bind to and kill tumor cells as they grow. 

The basis of the ADC mechanism comes from an observation of breast cell growth factors. About one-fifth of breast cancer patients show increased levels of human growth factor receptor 2 (HER2) on their tumor cell surfaces (breastcancer.org). Normal breast cell growth is harmless, but when too many HER2 genes are stimulating growth, cancer occurs. The ADC developed by the scientists from the University of Basel blocks the action of these malfunctioning receptors while simultaneously releasing cytotoxic chemicals that enter the tumor cell and instigate cell death.

In a study of mouse breast cancer models, the team combined ADC administration with immunotherapy treatments. By administering complementary antibodies to activate T lymphocytes, immunotherapy helps "reroute" the body's natural "immunoregulatory checkpoints" to ensure the right immune cells are being activated to fight the cancer. Without pairing immunotherapy with ADC treatment, T cell activation would not be as helpful. 

Combination therapy is a bright, new perspective for breast cancer treatment, and doctors like lead author Philipp Muller believe that "antibody-drug conjugates are suitable for use in a combination therapy."

Watch the following video to hear more about ADCs in detail.
Source: University of Basel
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 05, 2020
Coronavirus
Age-old Immune Components Affecting COVID-19 Severity
AUG 05, 2020
Age-old Immune Components Affecting COVID-19 Severity
One of the most unsettling aspects of the coronavirus pandemic is the wide range of severity those affected seem to expe ...
AUG 27, 2020
Immunology
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
AUG 27, 2020
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
  Living medicines in the form of stem cell therapies have immense potential for their ability to regenerate and he ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
OCT 26, 2020
Immunology
Gearing up for Life: The First 7 Days of the Immune System
OCT 26, 2020
Gearing up for Life: The First 7 Days of the Immune System
The mother’s placenta serves as a shield for the developing fetus inside the womb, protecting it from the constant ...
OCT 28, 2020
Microbiology
Immune Cells Link Gum Disease to Inflammatory DIsorders
OCT 28, 2020
Immune Cells Link Gum Disease to Inflammatory DIsorders
Scientists and clinicians know that oral health and inflammation, which is a part of many diseases, are connected.
NOV 10, 2020
Immunology
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
NOV 10, 2020
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
In the middle of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th ...
Loading Comments...